首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2930篇
  免费   200篇
  国内免费   149篇
耳鼻咽喉   7篇
儿科学   114篇
妇产科学   14篇
基础医学   240篇
口腔科学   39篇
临床医学   596篇
内科学   641篇
皮肤病学   34篇
神经病学   416篇
特种医学   406篇
外科学   130篇
综合类   52篇
预防医学   112篇
眼科学   31篇
药学   194篇
  1篇
肿瘤学   252篇
  2023年   19篇
  2021年   41篇
  2020年   27篇
  2019年   30篇
  2018年   41篇
  2017年   30篇
  2016年   36篇
  2015年   34篇
  2014年   35篇
  2013年   75篇
  2012年   60篇
  2011年   101篇
  2010年   82篇
  2009年   80篇
  2008年   125篇
  2007年   206篇
  2006年   96篇
  2005年   116篇
  2004年   98篇
  2003年   108篇
  2002年   95篇
  2001年   79篇
  2000年   69篇
  1999年   74篇
  1998年   88篇
  1997年   90篇
  1996年   90篇
  1995年   76篇
  1994年   52篇
  1993年   66篇
  1992年   58篇
  1991年   65篇
  1990年   56篇
  1989年   87篇
  1988年   67篇
  1987年   88篇
  1986年   56篇
  1985年   74篇
  1984年   53篇
  1983年   50篇
  1982年   40篇
  1981年   35篇
  1980年   33篇
  1979年   29篇
  1978年   34篇
  1977年   37篇
  1976年   43篇
  1975年   27篇
  1974年   19篇
  1971年   21篇
排序方式: 共有3279条查询结果,搜索用时 15 毫秒
1.
2.
高效液相色谱法测定人血浆中阿莫西林浓度及药代动力学   总被引:6,自引:0,他引:6  
谭力  周继红  罗楠  袁倚盛 《药学学报》1997,32(7):558-560
高效液相色谱法测定人血浆中阿莫西林浓度及药代动力学谭力周继红罗楠袁倚盛(南京军区南京总医院中心仪器分析科,南京210001)阿莫西林(amoxicilin)为β内酰胺类抗生素,其抗菌谱广,口服受食物影响小,对大多数病人耐受性良好,因而在临床上得以广泛...  相似文献   
3.
Alpha-Melanocyte-stimulating hormone (MSH) is a potent anti-inflammatory agent in many models of inflammation, suggesting that it inhibits a critical step common to different forms of inflammation. We showed previously that alpha-MSH inhibits nitric oxide (NO) production in cultured macro-phages. To determine how alpha-MSH acts in vivo, we induced acute hepatic inflammation by administering endotoxin (LPS) to mice pretreated with Corynebacterium parvum, alpha-MSH prevented liver inflammation even when given 30 min after LPS administration. To determine the mechanisms of action of alpha-MSH, we tested its influence on NO, infiltrating inflammatory cells, cytokines, and chemokines. Alpha-MSH inhibited systemic NO production, hepatic neutrophil infiltration, and increased hepatic mRNA abundance for TNF alpha, and the neutrophil and monocyte chemokines (KC/IL-8 and MCP-1). We conclude that alpha-MSH prevents LPS-induced hepatic inflammation by inhibiting production of chemoattractant chemokines which then modulate infiltration of inflammatory cells. Thus, alpha-MSH has an effect very early in the inflammatory cascade.  相似文献   
4.
The purpose of this study was to determine whether blood lipid and lipoprotein concentrations varied in 5 men with advanced HIV-1 infection after 12 months of aerobic exercise training. Prior to exercise, the mean baseline cholesterol and high-density lipoprotein cholesterol (HDL-C) serum concentration were each lower, and mean baseline triglyceride concentration was higher compared to a healthy population norm. Consistent exercise training for 12 months failed to significantly (p > .05) alter cholesterol or HDL-C. Triglyceride concentration was significantly (p < .05) elevated above baseline (63 mg/dL) regardless of exercise compliance. The results suggest that long-term exercise training cannot correct lipid profile abnormality, particularly hypertriglyceridemia, common to individuals with advanced HIV-1 infection.  相似文献   
5.
6.
Guidelines for design of clinical trials evaluating behavioral headache treatments were developed to facilitate production of quality research evaluating behavioral therapies for management of primary headache disorders. These guidelines were produced by a Workgroup of headache researchers under auspices of the American Headache Society. The guidelines are complementary to and modeled after guidelines for pharmacological trials published by the International Headache Society, but they address methodologic considerations unique to behavioral and other nonpharmacological treatments. Explicit guidelines for evaluating behavioral headache therapies are needed as the optimal methodology for behavioral (and other nonpharmacologic) trials necessarily differs from the preferred methodology for drug trials. In addition, trials comparing and integrating drug and behavioral therapies present methodological challenges not addressed by guidelines for pharmacologic research. These guidelines address patient selection, trial design for behavioral treatments and for comparisons across multiple treatment modalities (eg, behavioral vs pharmacologic), evaluation of results, and research ethics. Although developed specifically for behavioral therapies, the guidelines may apply to the design of clinical trials evaluating many forms of nonpharmacologic therapies for headache.  相似文献   
7.
Impaired recall for early items (primacy) and late items (recency) on word list recall tests are seen in Alzheimer's disease (AD). We compared conventional scoring on the Telephone Instrument for Cognitive Status (TICS) recall list with scorings based on retention-weighted recall (RWR: each item weighted by its serial position) in older adults participating in a community-based aging study. Subjects with mild AD (N=18) did not differ from those without dementia (N=231) with respect to recency (46% vs. 59%, p = 0.2), but had impaired primacy (2% vs. 39%, p < .001) on word recall on the TICS. RWR scoring improved the effect size (1.52 SD) compared to conventional scoring (1.08 SD). With a fixed sensitivity of 85%, specificity was lower using conventional scoring (56%) than RWR (76%) scoring. Our findings suggest that optimized RWR scoring of word list free recall can improve detection of mild AD compared to conventional scoring.  相似文献   
8.
9.
Adverse reaction to intravenous gadoteridol   总被引:1,自引:0,他引:1  
  相似文献   
10.
Migraine is a highly prevalent headache disorder that has a substantial impact on the individual and society. Over the past decade, substantial advances in research have increased understanding of the pathophysiology, diagnosis, epidemiology, and treatment of the disorder. This article reviews the burden of migraine, emphasizing the population-based studies that used standardized diagnostic criteria.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号